Global Antipsychotic Medicine Market Growth (Status and Outlook) 2025-2031

April 2025 | 114 pages | ID: GF4C17DF9E78EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Pneumatic Ballistic Shockwave Therapy Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

In The Field Of Clinical Medicine, Shock Wave Was First Used In Extracorporeal Shock Wave Lithotripsy. In The Late 1980s, Extracorporeal Shock Wave Lithotripsy Technology Began To Be Applied To The Field Of Orthopedics And Rehabilitation Physiotherapy. After More Than Ten Years Of Clinical Research, Shock Wave Therapy Has Become Increasingly Perfect. The Range Of Applications Is Also Expanding.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Pneumatic Ballistic Shockwave Therapy Devices Industry Forecast” looks at past sales and reviews total world Pneumatic Ballistic Shockwave Therapy Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Pneumatic Ballistic Shockwave Therapy Devices sales for 2025 through 2031. With Pneumatic Ballistic Shockwave Therapy Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumatic Ballistic Shockwave Therapy Devices industry.

This Insight Report provides a comprehensive analysis of the global Pneumatic Ballistic Shockwave Therapy Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumatic Ballistic Shockwave Therapy Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pneumatic Ballistic Shockwave Therapy Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumatic Ballistic Shockwave Therapy Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumatic Ballistic Shockwave Therapy Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumatic Ballistic Shockwave Therapy Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Focused Therapy Devices
  • Radiation Therapy Devices
Segmentation by Application:
  • Hospitals
  • Clinics
  • Physiotherapy Centers
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Boston Scientific Corporation
  • C.R. Bard Inc.
  • Dornier MedTech GmbH
  • Lumenis Ltd.
  • Medtrue Enterprise
  • Olympus Corporation
  • Cook Group
  • Edaptms TMS
  • Siemens AG
  • Karl Storz
  • STORZ Medical
  • Medispec
  • Astar
  • Chattanooga International
  • DermoEquipos
  • Hubei Oj Electronic Technology
  • Chongqing Seri Technology
  • Shanghai Lumsail Industrial Inc.
  • GUANGZHOU POTENT MEDICAL EQUIPMENT JOINT-STOCK
Key Questions Addressed in this Report

What is the 10-year outlook for the global Pneumatic Ballistic Shockwave Therapy Devices market?

What factors are driving Pneumatic Ballistic Shockwave Therapy Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pneumatic Ballistic Shockwave Therapy Devices market opportunities vary by end market size?

How does Pneumatic Ballistic Shockwave Therapy Devices break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antipsychotic Medicine Market Size (2020-2031)
  2.1.2 Antipsychotic Medicine Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Antipsychotic Medicine by Country/Region (2020, 2024 & 2031)
2.2 Antipsychotic Medicine Segment by Type
  2.2.1 Oral Antipsychotics
  2.2.2 Injectable Antipsychotics
2.3 Antipsychotic Medicine Market Size by Type
  2.3.1 Antipsychotic Medicine Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Antipsychotic Medicine Market Size Market Share by Type (2020-2025)
2.4 Antipsychotic Medicine Segment by Application
  2.4.1 Hospital Pharmacy
  2.4.2 Clinic Pharmacy
  2.4.3 Online Pharmacy
2.5 Antipsychotic Medicine Market Size by Application
  2.5.1 Antipsychotic Medicine Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Antipsychotic Medicine Market Size Market Share by Application (2020-2025)

3 ANTIPSYCHOTIC MEDICINE MARKET SIZE BY PLAYER

3.1 Antipsychotic Medicine Market Size Market Share by Player
  3.1.1 Global Antipsychotic Medicine Revenue by Player (2020-2025)
  3.1.2 Global Antipsychotic Medicine Revenue Market Share by Player (2020-2025)
3.2 Global Antipsychotic Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTIPSYCHOTIC MEDICINE BY REGION

4.1 Antipsychotic Medicine Market Size by Region (2020-2025)
4.2 Global Antipsychotic Medicine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antipsychotic Medicine Market Size Growth (2020-2025)
4.4 APAC Antipsychotic Medicine Market Size Growth (2020-2025)
4.5 Europe Antipsychotic Medicine Market Size Growth (2020-2025)
4.6 Middle East & Africa Antipsychotic Medicine Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Antipsychotic Medicine Market Size by Country (2020-2025)
5.2 Americas Antipsychotic Medicine Market Size by Type (2020-2025)
5.3 Americas Antipsychotic Medicine Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antipsychotic Medicine Market Size by Region (2020-2025)
6.2 APAC Antipsychotic Medicine Market Size by Type (2020-2025)
6.3 APAC Antipsychotic Medicine Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Antipsychotic Medicine Market Size by Country (2020-2025)
7.2 Europe Antipsychotic Medicine Market Size by Type (2020-2025)
7.3 Europe Antipsychotic Medicine Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antipsychotic Medicine by Region (2020-2025)
8.2 Middle East & Africa Antipsychotic Medicine Market Size by Type (2020-2025)
8.3 Middle East & Africa Antipsychotic Medicine Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTIPSYCHOTIC MEDICINE MARKET FORECAST

10.1 Global Antipsychotic Medicine Forecast by Region (2026-2031)
  10.1.1 Global Antipsychotic Medicine Forecast by Region (2026-2031)
  10.1.2 Americas Antipsychotic Medicine Forecast
  10.1.3 APAC Antipsychotic Medicine Forecast
  10.1.4 Europe Antipsychotic Medicine Forecast
  10.1.5 Middle East & Africa Antipsychotic Medicine Forecast
10.2 Americas Antipsychotic Medicine Forecast by Country (2026-2031)
  10.2.1 United States Market Antipsychotic Medicine Forecast
  10.2.2 Canada Market Antipsychotic Medicine Forecast
  10.2.3 Mexico Market Antipsychotic Medicine Forecast
  10.2.4 Brazil Market Antipsychotic Medicine Forecast
10.3 APAC Antipsychotic Medicine Forecast by Region (2026-2031)
  10.3.1 China Antipsychotic Medicine Market Forecast
  10.3.2 Japan Market Antipsychotic Medicine Forecast
  10.3.3 Korea Market Antipsychotic Medicine Forecast
  10.3.4 Southeast Asia Market Antipsychotic Medicine Forecast
  10.3.5 India Market Antipsychotic Medicine Forecast
  10.3.6 Australia Market Antipsychotic Medicine Forecast
10.4 Europe Antipsychotic Medicine Forecast by Country (2026-2031)
  10.4.1 Germany Market Antipsychotic Medicine Forecast
  10.4.2 France Market Antipsychotic Medicine Forecast
  10.4.3 UK Market Antipsychotic Medicine Forecast
  10.4.4 Italy Market Antipsychotic Medicine Forecast
  10.4.5 Russia Market Antipsychotic Medicine Forecast
10.5 Middle East & Africa Antipsychotic Medicine Forecast by Region (2026-2031)
  10.5.1 Egypt Market Antipsychotic Medicine Forecast
  10.5.2 South Africa Market Antipsychotic Medicine Forecast
  10.5.3 Israel Market Antipsychotic Medicine Forecast
  10.5.4 Turkey Market Antipsychotic Medicine Forecast
10.6 Global Antipsychotic Medicine Forecast by Type (2026-2031)
10.7 Global Antipsychotic Medicine Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Antipsychotic Medicine Forecast

11 KEY PLAYERS ANALYSIS

11.1 Johnson and Johnson
  11.1.1 Johnson and Johnson Company Information
  11.1.2 Johnson and Johnson Antipsychotic Medicine Product Offered
  11.1.3 Johnson and Johnson Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Johnson and Johnson Main Business Overview
  11.1.5 Johnson and Johnson Latest Developments
11.2 Eli Lilly
  11.2.1 Eli Lilly Company Information
  11.2.2 Eli Lilly Antipsychotic Medicine Product Offered
  11.2.3 Eli Lilly Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Eli Lilly Main Business Overview
  11.2.5 Eli Lilly Latest Developments
11.3 Bristol-Myers Squibb
  11.3.1 Bristol-Myers Squibb Company Information
  11.3.2 Bristol-Myers Squibb Antipsychotic Medicine Product Offered
  11.3.3 Bristol-Myers Squibb Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bristol-Myers Squibb Main Business Overview
  11.3.5 Bristol-Myers Squibb Latest Developments
11.4 AstraZeneca
  11.4.1 AstraZeneca Company Information
  11.4.2 AstraZeneca Antipsychotic Medicine Product Offered
  11.4.3 AstraZeneca Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AstraZeneca Main Business Overview
  11.4.5 AstraZeneca Latest Developments
11.5 Novartis
  11.5.1 Novartis Company Information
  11.5.2 Novartis Antipsychotic Medicine Product Offered
  11.5.3 Novartis Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Novartis Main Business Overview
  11.5.5 Novartis Latest Developments
11.6 Allergan
  11.6.1 Allergan Company Information
  11.6.2 Allergan Antipsychotic Medicine Product Offered
  11.6.3 Allergan Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Allergan Main Business Overview
  11.6.5 Allergan Latest Developments
11.7 Pfizer
  11.7.1 Pfizer Company Information
  11.7.2 Pfizer Antipsychotic Medicine Product Offered
  11.7.3 Pfizer Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Pfizer Main Business Overview
  11.7.5 Pfizer Latest Developments
11.8 GlaxoSmithKline
  11.8.1 GlaxoSmithKline Company Information
  11.8.2 GlaxoSmithKline Antipsychotic Medicine Product Offered
  11.8.3 GlaxoSmithKline Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 GlaxoSmithKline Main Business Overview
  11.8.5 GlaxoSmithKline Latest Developments
11.9 Otsuka Pharma
  11.9.1 Otsuka Pharma Company Information
  11.9.2 Otsuka Pharma Antipsychotic Medicine Product Offered
  11.9.3 Otsuka Pharma Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Otsuka Pharma Main Business Overview
  11.9.5 Otsuka Pharma Latest Developments
11.10 Sumitomo Dainippon
  11.10.1 Sumitomo Dainippon Company Information
  11.10.2 Sumitomo Dainippon Antipsychotic Medicine Product Offered
  11.10.3 Sumitomo Dainippon Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Sumitomo Dainippon Main Business Overview
  11.10.5 Sumitomo Dainippon Latest Developments
11.11 Alkermes
  11.11.1 Alkermes Company Information
  11.11.2 Alkermes Antipsychotic Medicine Product Offered
  11.11.3 Alkermes Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Alkermes Main Business Overview
  11.11.5 Alkermes Latest Developments
11.12 Vanda Pharma
  11.12.1 Vanda Pharma Company Information
  11.12.2 Vanda Pharma Antipsychotic Medicine Product Offered
  11.12.3 Vanda Pharma Antipsychotic Medicine Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Vanda Pharma Main Business Overview
  11.12.5 Vanda Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Antipsychotic Medicine Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Antipsychotic Medicine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral Antipsychotics
Table 4. Major Players of Injectable Antipsychotics
Table 5. Antipsychotic Medicine Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Antipsychotic Medicine Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Antipsychotic Medicine Market Size Market Share by Type (2020-2025)
Table 8. Antipsychotic Medicine Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Antipsychotic Medicine Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Antipsychotic Medicine Market Size Market Share by Application (2020-2025)
Table 11. Global Antipsychotic Medicine Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Antipsychotic Medicine Revenue Market Share by Player (2020-2025)
Table 13. Antipsychotic Medicine Key Players Head office and Products Offered
Table 14. Antipsychotic Medicine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Antipsychotic Medicine Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Antipsychotic Medicine Market Size Market Share by Region (2020-2025)
Table 19. Global Antipsychotic Medicine Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Antipsychotic Medicine Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Antipsychotic Medicine Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Antipsychotic Medicine Market Size Market Share by Country (2020-2025)
Table 23. Americas Antipsychotic Medicine Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Antipsychotic Medicine Market Size Market Share by Type (2020-2025)
Table 25. Americas Antipsychotic Medicine Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Antipsychotic Medicine Market Size Market Share by Application (2020-2025)
Table 27. APAC Antipsychotic Medicine Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Antipsychotic Medicine Market Size Market Share by Region (2020-2025)
Table 29. APAC Antipsychotic Medicine Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Antipsychotic Medicine Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Antipsychotic Medicine Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Antipsychotic Medicine Market Size Market Share by Country (2020-2025)
Table 33. Europe Antipsychotic Medicine Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Antipsychotic Medicine Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Antipsychotic Medicine Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Antipsychotic Medicine Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Antipsychotic Medicine Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Antipsychotic Medicine
Table 39. Key Market Challenges & Risks of Antipsychotic Medicine
Table 40. Key Industry Trends of Antipsychotic Medicine
Table 41. Global Antipsychotic Medicine Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Antipsychotic Medicine Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Antipsychotic Medicine Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Antipsychotic Medicine Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Johnson and Johnson Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 46. Johnson and Johnson Antipsychotic Medicine Product Offered
Table 47. Johnson and Johnson Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Johnson and Johnson Main Business
Table 49. Johnson and Johnson Latest Developments
Table 50. Eli Lilly Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 51. Eli Lilly Antipsychotic Medicine Product Offered
Table 52. Eli Lilly Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Eli Lilly Main Business
Table 54. Eli Lilly Latest Developments
Table 55. Bristol-Myers Squibb Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 56. Bristol-Myers Squibb Antipsychotic Medicine Product Offered
Table 57. Bristol-Myers Squibb Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. AstraZeneca Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 61. AstraZeneca Antipsychotic Medicine Product Offered
Table 62. AstraZeneca Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. AstraZeneca Main Business
Table 64. AstraZeneca Latest Developments
Table 65. Novartis Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 66. Novartis Antipsychotic Medicine Product Offered
Table 67. Novartis Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Novartis Main Business
Table 69. Novartis Latest Developments
Table 70. Allergan Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 71. Allergan Antipsychotic Medicine Product Offered
Table 72. Allergan Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Allergan Main Business
Table 74. Allergan Latest Developments
Table 75. Pfizer Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 76. Pfizer Antipsychotic Medicine Product Offered
Table 77. Pfizer Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. GlaxoSmithKline Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 81. GlaxoSmithKline Antipsychotic Medicine Product Offered
Table 82. GlaxoSmithKline Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. GlaxoSmithKline Main Business
Table 84. GlaxoSmithKline Latest Developments
Table 85. Otsuka Pharma Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 86. Otsuka Pharma Antipsychotic Medicine Product Offered
Table 87. Otsuka Pharma Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Otsuka Pharma Main Business
Table 89. Otsuka Pharma Latest Developments
Table 90. Sumitomo Dainippon Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 91. Sumitomo Dainippon Antipsychotic Medicine Product Offered
Table 92. Sumitomo Dainippon Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Sumitomo Dainippon Main Business
Table 94. Sumitomo Dainippon Latest Developments
Table 95. Alkermes Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 96. Alkermes Antipsychotic Medicine Product Offered
Table 97. Alkermes Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Alkermes Main Business
Table 99. Alkermes Latest Developments
Table 100. Vanda Pharma Details, Company Type, Antipsychotic Medicine Area Served and Its Competitors
Table 101. Vanda Pharma Antipsychotic Medicine Product Offered
Table 102. Vanda Pharma Antipsychotic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Vanda Pharma Main Business
Table 104. Vanda Pharma Latest Developments



LIST OF FIGURES

Figure 1. Antipsychotic Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antipsychotic Medicine Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Antipsychotic Medicine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Antipsychotic Medicine Sales Market Share by Country/Region (2024)
Figure 8. Antipsychotic Medicine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Antipsychotic Medicine Market Size Market Share by Type in 2024
Figure 10. Antipsychotic Medicine in Hospital Pharmacy
Figure 11. Global Antipsychotic Medicine Market: Hospital Pharmacy (2020-2025) & ($ millions)
Figure 12. Antipsychotic Medicine in Clinic Pharmacy
Figure 13. Global Antipsychotic Medicine Market: Clinic Pharmacy (2020-2025) & ($ millions)
Figure 14. Antipsychotic Medicine in Online Pharmacy
Figure 15. Global Antipsychotic Medicine Market: Online Pharmacy (2020-2025) & ($ millions)
Figure 16. Global Antipsychotic Medicine Market Size Market Share by Application in 2024
Figure 17. Global Antipsychotic Medicine Revenue Market Share by Player in 2024
Figure 18. Global Antipsychotic Medicine Market Size Market Share by Region (2020-2025)
Figure 19. Americas Antipsychotic Medicine Market Size 2020-2025 ($ millions)
Figure 20. APAC Antipsychotic Medicine Market Size 2020-2025 ($ millions)
Figure 21. Europe Antipsychotic Medicine Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Antipsychotic Medicine Market Size 2020-2025 ($ millions)
Figure 23. Americas Antipsychotic Medicine Value Market Share by Country in 2024
Figure 24. United States Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Antipsychotic Medicine Market Size Market Share by Region in 2024
Figure 29. APAC Antipsychotic Medicine Market Size Market Share by Type (2020-2025)
Figure 30. APAC Antipsychotic Medicine Market Size Market Share by Application (2020-2025)
Figure 31. China Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 35. India Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Antipsychotic Medicine Market Size Market Share by Country in 2024
Figure 38. Europe Antipsychotic Medicine Market Size Market Share by Type (2020-2025)
Figure 39. Europe Antipsychotic Medicine Market Size Market Share by Application (2020-2025)
Figure 40. Germany Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 41. France Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Antipsychotic Medicine Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Antipsychotic Medicine Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Antipsychotic Medicine Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Antipsychotic Medicine Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 54. APAC Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 55. Europe Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 57. United States Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 58. Canada Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 59. Mexico Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 60. Brazil Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 61. China Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 62. Japan Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 63. Korea Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 65. India Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 66. Australia Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 67. Germany Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 68. France Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 69. UK Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 70. Italy Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 71. Russia Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 72. Egypt Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 73. South Africa Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 74. Israel Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 75. Turkey Antipsychotic Medicine Market Size 2026-2031 ($ millions)
Figure 76. Global Antipsychotic Medicine Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Antipsychotic Medicine Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Antipsychotic Medicine Market Size 2026-2031 ($ millions)